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Available online 28 September 2014Abstract Deletion studies confirm Wnt, Notch and Myb transcriptional pathway engagement in intestinal tumorigenesis.
Nevertheless, their contrasting and combined roles when activated have not been elucidated. This is important as these
pathways are not ablated but rather are aberrantly activated during carcinogenesis. Using ApcMin/+ mice as a source of
organoids we documented their transition, on a clone-by-clone basis, to cyst-like spheres with constitutively activated Wnt
pathway, increased self-renewal and growth and reduced differentiation. We then looked at this transition when Myb and/or
Notch1 are activated. Activated Notch promoted cyst-like organoids. Conversely growth and propagation of cyst-like, but not
normal organoids were Notch-independent. Activated Myb promoted normal, but not cyst-like organoids. Interestingly the
Wnt, Notch and Myb pathways were all involved in regulating the expression of the intestinal stem cell (ISC) gene Lgr5 in
organoids, while ISC gene and Notch target Olfm4 was dominantly repressed by Wnt. These findings parallel mouse intestinal
adenoma formation where Notch promoted the initiation, but not growth, of Wnt-driven Olfm4-repressed colon tumors. Also
Myb was essential for colon tumor initiation and collateral mouse pathologies. These data reveal the complex interplay and
hierarchy of transcriptional networks that operate in ISCs and uncover a shift in pathway-dependencies during tumor initiation.
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Linear transcriptional pathways that govern intestinal
tumorigenesis have been extensively explored in mice using
gene knock outs (KO) and to a limited extent hypomorphs as
well as chemical inhibitors (Aoki and Taketo, 2007; Barker et
al., 2009, 2010; Batlle et al., 2005; Cheasley et al., 2011;en access article under the CC BY license
356 M. Germann et al.Fre et al., 2005, 2011; Malaterre et al., 2007; Muncan et al.,
2006; Sansom et al., 2007; Taketo, 2006). Specifically these
studies on the Wnt, Notch and Myb pathways confirm a
dependency on their various downstream target genes but do
not necessarily address the cross-talk between these pathways
when they are instead activated. An additional consequence
of gene deletion studies is that changes in disease course can
be due to the actual loss of the very cells that are normally
subject to transformation. To address these gaps we have
focused on these three transcriptional programs that are
activated in intestinal cancers and that have been shown to
interact with each other (Cheasley et al., 2011; Ciznadija et
al., 2009; Fre et al., 2009). To do this we have generated
compound transgenic and mutant mice that modulate all
three pathways and followed the earliest events in stem/
progenitor cell (ISC) transformation in vitro and in vivo.
ISCs are at the nexus of the hierarchical organization of
the intestinal epithelium, producing cells which give rise to
differentiated enterocytes, enteroendocrine cells, Paneth
cells, goblet cells, Tuft cells and Peyer's Patch M cells
(Barker et al., 2010). To guarantee the lifelong maintenance
of the tissue, the ISC/progenitor cell compartment has to be
tightly regulated by several molecular pathways that control
ISC self-renewal, proliferation and differentiation.
The Wnt pathway is active in ISCs and is essential for their
self-renewal (Korinek et al., 1998) as well as Paneth cell
differentiation (Andreu et al., 2005; Farin et al., 2012; van
Es et al., 2005a). Activation of the Wnt pathway leads to
stabilization of cytoplasmic and nuclear β-catenin, which
interacts with other proteins to induce the expression of
genes such as Lgr5 and Ascl2 in ISCs (Barker et al., 2007; van
der Flier et al., 2009), Myc and Ccnd1 (Andreu et al., 2005),
as well as Cryptidin, and Lysozyme genes in Paneth cells
(Andreu et al., 2005; van Es et al., 2005a). Similarly, the
Notch pathway (Kopan and Ilagan, 2009) is essential for ISC
self-renewal and differentiation (Pellegrinet et al., 2011).
Notch is clearly active in ISCs (Fre et al., 2011; Smith et
al., 2012) and stimulates proliferation (Fre et al., 2005,
2009) while blocking secretory cell differentiation (Fre et
al., 2005, 2011; van Es et al., 2005b). Furthermore, Notch is
a direct activator of the ISC gene Olfm4 (VanDussen et al.,
2012) and the bHLH transcriptional repressor Hes1, which in
turn blocks expression of the driver of secretory cell
differentiation, Math1 (Jensen et al., 2000; Yang et al.,
2001). The co-operation between Notch and Wnt in the
intestine results in the amplification of Wnt-driven prolifer-
ation and Wnt-driven tumor formation is potentiated by
constitutive Notch activation (Fre et al., 2009). Conversely,
Wnt target genes are repressed by Notch signaling and
negatively correlate with the Notch target gene Nrarp
expression in CRC (Kim et al., 2012).
Myb is additionally active in ISCs where it is essential for
self-renewal and blockade of goblet cell differentiation
(Cheasley et al., 2011; Malaterre et al., 2007). Furthermore,
we have demonstrated that Myb is crucially involved in the
regulation of the Wnt target genes Myc and Lgr5 in ISCs
(Cheasley et al., 2011; Ciznadija et al., 2009). Myb is
over-expressed in human CRC (Ramsay and Gonda, 2008) and
Myb heterozygous deletion prolongs survival of intestinal
cancer-prone Apc mutant mice (Ciznadija et al., 2009),
indicating that Myb is involved in Wnt-dependent intestinal
tumor formation.Given these reported network interactions between Wnt,
Notch and Myb in ISCs and CRC, we considered it important
to explore their combined roles in controlling intestinal
homeostasis and tumor formation. Thus far these three
pathways have been investigated individually or perhaps in
dual combinations and therefore this tripartite hierarchy
remains uninvestigated. We found that Wnt, Notch and Myb
activation had distinct effects on key ISC gene expression
patterns, that the effects of full Wnt activation were
dependent upon functional Myb expression, co-operated
with activated Notch and were resistant to Notch inhibition.
These data set the stage to hierarchically order the roles of
these three pathways in ISC function and in intestinal
transformation.
Materials and methods
Mice
VilCreERT2/NotchIC mice (Fre et al., 2009) and ApcMin/+ (Min)
mice (Moser et al., 1990) have been described previously. Myb
heterozygous knock-out mice and their intestinal defects have
been described elsewhere (Ciznadija et al., 2009). MybER mice
contain a transgene encoding a Tamoxifen-inducible fusion
protein between Myb and the ERα-ligand binding domain
driven by the intestinal-specific promoter, gpa33 (Malaterre et
al., 2007). All mice were maintained on a C57/BL6 background.
To activate MybER or VilCreERT2 proteins, mice were fed for
seven days with chow containing Tamoxifen (Sigma, Castle
Hill, Australia) to a total of 1 g/kg body weight. Min interbred
mice were observed for any signs intestinal bleeding or ill
health according the Peter MacCallum Cancer Centre Animal
Experimentation Ethics Committee regulations. Sick mice were
killed and their colon and SI were evaluated for the presence
and size of adenomas and fixed in 10% neural buffered
formalin.
Organoid culture
Briefly, 1000–2000 crypt nests were seeded in 50 μl Phenol
red-free Matrigel (BD Biosciences, North Ryde, Australia)
and over-layed with 500 μl of specific medium as described
(Cheasley et al., 2011; Sato et al., 2009) including 100 nM of
4-Hydroxy-Tamoxifen (4-OHT, Sigma). Primary (1°) organoids
were scored on day 1 and organoids (with at least one crypt-like
projection) on day 7 after seeding. Organoid colony formation
efficiency was calculated as ratio of day 1/day 7 scores.
Organoid growth was measured using an MTT assay as described
(Cheasley et al., 2011). Established organoids were extracted
from Matrigel using Dispase (BD Biosciences) and dissociated
using Accutase (Accumax, Merck Millipore, Kilsyth, Australia)
followed by trituration with a fine polished glass pipette. Cell
suspensions were seeded in Matrigel as described above in the
presence of Rho-kinase inhibitor (Sigma) to prevent anoikis (Sato
et al., 2009). Formation of secondary (2°) organoids was scored
after 8 to 10 days. Self-renewal capacity was calculated as
number of 2° organoids formed/number of dissociated 1°
organoids used for 2° culture. To block Notch signaling, primary
organoids were treated with Dibenzazepine (DBZ, Calbiochem,
Merck Millipore) or vehicle alone (DMSO, Sigma) one day after
seeding with addition of fresh DBZ or DMSO for the next three
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paraformaldehyde and embedded in agarose for immunohisto-
chemistry or lysed in Trizol for RNA/DNA extraction.
Reporter assays
pCATbasic reporter constructs containing the human Myb
or Myc promoters, as well as plasmids encoding for
full-length MYB or Δ89-β-catenin have been described
elsewhere (Ciznadija et al., 2009). The pBabe-N1IC
vector was generated by cloning the cDNA (residues
1759–2556), encoding mouse intracellular Notch1 into
the pBabePuro vector. HEK293 cells were transfected
with plasmids using X-tremeGENE9 reagent and CAT
expression was measured by a CAT ELISA kit (Roche,
Castle Hill, Australia).
Immunohistochemistry and morphometric analyses
Immunohistochemical staining was carried out on sec-
tions of fixed, paraffin embedded tissues or organoids.
Antibodies are listed in Supplemental information Table S1.
Sections were dewaxed and blocked for endogenous
peroxidase with 3% hydrogen peroxide prior to antibody
incubation. Sections were counterstained with Periodic
acid/Schiffs (PAS) reagent to mark secretory cells and with
Hematoxylin and Eosin and images captured using an Olympus
BH-2 microscope.
Real-time PCR and candidate gene expression
RNA was extracted from samples stored in Trizol (BioRad,
Gladesville, Australia) according to the manufacturer's
instructions. cDNA synthesis was carried out after DNase
treatment of RNA (RQ1 DNase, Promega, Alexandria,
Australia) using M-MLV, RNaseH-reverse transcriptase and
random hexamer primers (Promega). Real-time PCR was
carried out on a StepOne thermal cycler (Life Technologies,
Mulgrave, Australia) using gene specific primers (Supple-
mental information Table S1) and Fast SYBR Green (Life
Technologies).
Apc allelic distribution assay
Individual organoids were picked under a dissecting micro-
scope, incubated in lysis buffer (5 mM Tris–HCl pH 8.8;
2.5 mM (NH4)2SO4; 1 mM MgCl2; 0.5% Triton-X100 and
0.4 mg/ml Proteinase K) for 60 min at 55 °C, and PCR
amplification was performed using cell lysates as tem-
plate. Amplified products were digested with HindIII and
separated on 10% acrylamide gels for detecting ApcWT
and ApcMin alleles as described previously (Moser et al.,
1992).
Statistical analysis
Statistical analysis was performed with GraphPad Prism
Version 6 (GraphPad Software Inc., La Jolla, USA). Differ-
ences between groups were analyzed by t-test. When
distribution of values per group did not pass the KS normalitytest, the Mann–Whitney test was used. When variances were
significantly different (F-test) a t-test with Welch's correc-
tion was used.
The Supplementary information section accompanies the
paper on the Stem Cell Research website.
Results
Demonstrating pathway activation in vitro
The SI organoid culture method has become an invaluable in
vitro tool to investigate intestinal cell biology particularly
when this approach is combined in parallel with animal studies
(Sato et al., 2009). By doing so, it has been demonstrated by
gene loss or mutation that the Wnt, Notch and Myb pathways
are essential for crypt homeostasis, organoid formation and
ISC function (Cheasley et al., 2011; van Es et al., 2012;
VanDussen et al., 2012). Here, we investigated whether
converse effects can be observed when these pathways are
activated alone and then in combination. To do this we
employed mice carrying a mutation in one allele of the Apc
gene (Min) (Moser et al., 1990), an intestinal specific,
inducible-form of Myb (MybER) (Ramsay et al., 2005;
Malaterre et al., manuscript submitted) and an intestinal-
specific, inducible model employing the Notch intracellular
domain (NotchIC) (Murtaugh et al., 2003) as a source of crypts
to establish organoid culture.
Establishing an in vitro model for progressive
activation of Wnt signaling
To avoid any differences in ISC stromal influences from one
mouse line to another we first addressed the effects of
activated pathways on an individual basis using SI organoid
cultures with the same reagents. Also note that all mice
were breed onto a C57BL/6 background for at least 10
generations. As Wnt activation is generally accepted as a
feature of most intestinal cancers and core to ISC function
we began with the Wnt pathway finding as expected that
primary (1°) SI organoids from Min mice were indistinguish-
able from matched WT cultures in terms of expression of
Wnt targets Ascl2 (van der Flier et al., 2009) and Ccnd1
(Andreu et al., 2005) (Figs. 1A and B).
First we established an assay that allows differential
RFLP PCR amplification of ApcWT and ApcMin alleles in
crypts and adenoma DNA (Fig. 1C). We extracted DNA
from individual organoids to show they were genotypi-
cally heterozygous for Apc alleles (Fig. 1D). However, it
was also evident that a small proportion of crypt nests
gave rise to cyst-like structures and these were most
prominent when primary organoids (Min 1°) were dis-
persed and replated to form secondary organoids (Min
2°). Under these conditions most had lost the ApcWT
allele (Fig. 1D). When total RNA was isolated from the
secondary cultures and examined for Ascl2 and Ccnd1
expression it was now clear in these that the Wnt pathway
was activated (Figs. 1A and B).
To explore the transition from 1° organoids to 2° cyst-like
cultures in greater detail we performed morphological,
immunohistochemical (IHC) and gene expression studies. A
substantial number of Min 1° organoids displayed a cyst-like
Figure 1 Loss of the ApcWT allele in Min organoids leads to immediate Wnt activation in vitro. (A–B) Passaging of primary (1°) into
secondary (2°) SI intestinal organoid cultures leads to immediate expression of Wnt target genes, Ascl2 and Ccnd1 respectively
compared to WT SI organoids. Mean ± SEM; *p b 0.05, n N 3. (C) A PCR-based assay identifies the ApcMin and ApcWT alleles in SI
crypts from Min and WT mice and in adenomas from Min mice. (D) Individual organoids established from three Min mice were
processed to determine the status of the Apc alleles.
358 M. Germann et al.structure (Fig. 2A). Normal organoids initially form small
spheres and mainly grow by budding and expansion of
crypt-like structures from these spheroids (Clevers and
Nusse, 2012). By contrast and despite partial initiation of
budding, cyst-like organoids did not contain crypt-like
structures, but rather retained their spherical shape during
growth (Figs. 2A and B).
Cyst-like organoids have previously been described to form
from SI cells with imposed ApcWT-loss (Jarde et al., 2013),
when the Wnt/β-catenin pathway was hyperactivated in
vitro (Onuma et al., 2013; Sato et al., 2011b) or from
intestinal adenoma derived cells (Sato et al., 2011a).
Cyst-like organoids displayed strong staining for cytoplas-
mic and nuclear β-catenin and an absence of PAS+/
goblet-like cells (Figs. 2C and D). This phenotype was more
pervasive in Min 2° organoids and indistinguishable from
organoids derived directly from adenomas in Min mice
(Supplementary Fig. 1). We consistently observed some
cyst-like organoids also in Min 1° organoid cultures (Fig. 2A).
Nevertheless, in our hands, all single Min 1° organoids still
contained cells harboring the ApcWT allele, but the overall
abundance of the ApcWT allele was still lower than the
ApcMin allele (Fig. 1D). This was based upon quantitative
gel scanning where the ratio of the ApcMin allele to the
ApcWT allele was mostly b1.2 in the primary organoid
cultures while in the secondary organoids the ApcMin allele
predominated and thus the ratio was N1.5.
After dissociation and passaging, the 2° organoids formed
were predominantly cyst-like (Fig. 2A) and negative for theApcWT allele (Fig. 1D). It was thus apparent that there was a
selective advantage for cells initiating cyst-like organoids
over cells initiating conventional-looking organoids on
replating as secondary cultures (Fig. 2E). This assay is
essentially a test of self-renewal capacity and was investi-
gated in more detail as described below. In accord with the
fact that ApcWT-loss results in constitutive Wnt pathway
activation (Korinek et al., 1997; Sansom et al., 2004), Min 2°
organoid cultures with a high percentage of cyst-like
organoids displayed an increase in the Wnt target and ISC
marker gene Lgr5, but a surprising and significant decrease
in Olfm4, while the relatively low Bmi1 or mTert expression
remained unchanged (Fig. 3). Stem cell gene expression
signatures in Min 1° organoids was indistinguishable fromWT 1°
organoids (data not shown).
Taken together our results suggest that cyst-like Min 2°
organoids arise from Olfm4-negative cells with Wnt hyper-
activation through loss of ApcWT. Furthermore, the general
expansion of cyst-like organoids and cells with ApcWT-loss
in 2° cultures implies that the cells initiating cyst-like
growth have a very high organoid re-forming and, thus,
self-renewal capacity. Hyperactivation of the Wnt pathway
in concert with an expansion of ISC-like cells with high
proliferative potential is also observed in intestinal adeno-
mas formed following loss of ApcWT or constitutively active
β-catenin in mice in vivo (Barker et al., 2009; Moser et al.,
1992; Schepers et al., 2012; Schwitalla et al., 2013).
Further, Apc-inactivated cyst-like organoids are tumori-
genic when injected into mice (Onuma et al., 2013). Thus,
Figure 2 Characterization of primary (1°) and secondary (2°) organoids derived from Min mice. (A) Primary Min organoids generate
either characteristic morphologies indistinguishable from those of WT organoids or cyst-like organoids. Budding was most evident in
normal organoids and only to a minor extent in cyst-like organoids (red arrows). (B) Cyst-like organoids become predominant in
secondary cultures. Few retain minimally budding structures (upper panel), but the majority grows completely as spheres (lower
panel). (C–D) Cyst-like organoids show intense nuclear β-catenin staining compared to membrane staining in those organoids which
also had persistent mucin staining detected by PAS histochemistry. (E) Cyst-like organoids arise preferentially when passaged
individually to secondary cultures. Each dot represents organoid culture from one mouse and its derived secondary organoid culture,
p = 0.008; paired t-test.
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processes of ApcWT-loss and adenoma formation in vitro.
Notch and Myb activation have distinct effects on
organoid formation
Having defined the conditions under which Wnt pathway
activation could be readily monitored we then explored the
effects of activating Myb and Notch. To test the effect of
Myb activation SI crypt nests derived from MybER and
NotchIC:VilCreERT2 mice were cultured in the presence ofFigure 3 Activation and suppression of ISC genes occur following lo
ISC marker gene Olfm4 reduced while Lgr5 is increased in ApcMin/
other ISC genes Bmi1 and mTert was not significantly changed (*: p4-hydroxytamoxifen (4OHT). These were then compared in
their respective abilities to form organoids and to WT and
Min mice-derived SI crypt nests (1° organoids). MybER
organoid formation was superior to the other genotypes
(Fig. 4A) while only Min organoids showed significantly
greater self-renewal (Fig. 4B) commensurate with the
generation of cyst-like colonies which we showed above to
be responsible for this increased 2° organoid formation.
Interestingly, the combined genotypes in the MybER/Min/
+organoids do not lead to increased organoid formation
above that observed in WT cultures.ss of the ApcWT allele in Min organoids. (A–B) mRNA levels of the
Min organoids compared to WT organoids. (C–D) Expression of
b 0.05; **: p b 0.01).
Figure 4 Activation of Myb and Notch differentially promotes organoid formation and target gene expression. (A) Activated MybER
increases the relative organoid forming efficiency compared to WT, Min and NotchIC cultures; all cultures were exposed to 4OHT.
Organoid formation was calculated as organoids formed on day 7 per crypt nest present on day 1 of culture. (B) 2° organoid formation
is significantly increased in Min cultures. Self-renewal capacity of organoids determined by the number of 2° organoids formed when 1°
organoids were dissociated into single cells and replated; each dot represents one mouse and values were derived from at least 5
independent experiments. (C) Expression ofMyc increased significantly in primary MybER cultures. (D) NotchIC activates Lgr5 expression
and this is compromised when one allele of Myb is lost. (E–F) Notch target genes Olfm4 and Nrarp are increased in NotchIC organoids but
essentially unaffected by Myb heterozygosity. (*: p b 0.05: **: p b 0.01).
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only in the MybER cultures (Fig. 4C) even though Myc has
been reported to be a NotchIC target gene (Efstratiadis et
al., 2007; Klinakis et al., 2006) and of note a Wnt target gene
(He et al., 1998). By contrast, NotchIC organoids showed
significantly higher Lgr5, Olfm4 and Nrarp expression
compared to the others (Figs. 4D–F). As reported previously
normal Myb function is required for Lgr5 expression even
when Wnt activation is robust (Cheasley et al., 2011) and
similarly hyperactivated-Notch still appears to require
normal levels of Myb expression to allow it activate Lgr5
expression (Fig. 4D).
To begin to understand the interaction between Notch and
Wnt in vitro we investigated the effect of the γ-secretase
inhibitor DBZ in the context of Min organoid formation. We
immediately noted that in the presence of the relatively low
dose of 0.1 μM DBZ that normal-appearing organoids were
essentially absent while cyst-like organoids were predominant
(Figs. 5A and B). In these 1° organoid cultures it was also
apparent that cyst-like organoids remained resistant to higher
DBZ concentrations (Fig. 5C). We then confirmed that these
DBZ-resistant organoids were of an ApcMin/Min genotype in
three different mice (Fig. 5D) and were at a selective
advantage compared to ApcMin/+organoids (Fig. 5E). They
also retained the high self-renewal potential of unselected
cyst-like organoids (Fig. 5F). In contrast to ApcMin/Min MybER
did not circumvent Notch-dependence for self-renewal
(Fig. 5F). Conversely, the presence of NotchIC doubled the
percentage of cyst-like organoids (Fig. 5G). Collectively thesedata indicate that while normal Notch signaling is essential to
normal organoid formation Min/Min cyst-like organoids are
resistant to γ-secretase inhibition and therefore appear
independent of Notch signaling. Conversely, the activation of
Notch increases cyst-like organoid generation.
Finally, with regard to the effects of lineage specifica-
tion in the context of different pathway activation we
focused on goblet cells because they are readily quantifi-
able in SI tissue sections. Overall, we found that activation
of Notch and Myb reduced goblet cell frequency in the SI
(Supplementary Fig. 3), while ApcMin/+ are indistinguishable
from WT until the second ApcWT allele is converted to the
ApcMin allele.
Myb and Notch are involved in Wnt-mediated colon
adenoma initiation
Activating mutations within the Wnt pathway are found in
the majority of CRC patients (Kinzler and Vogelstein, 1996;
Powell et al., 1992; Sparks et al., 1998). The Min/+ mouse
model has been exploited and studied as an analogue to
Familial Adenomatous Polyposis (FAP), a heritable disease
where patients develop multiple colon polyps. Here we
crossed several mouse lines to determine the interactions
between the Wnt activation and the two other transcrip-
tional programs in the intestines to evaluate how these
might affect the course of tumorigenesis.
In agreement with our previous studies (Ciznadija et al.,
2009; Fre et al., 2011) in Apc deficient mice, Myb deficiency
Figure 5 Notch activation selectively favors cyst-like organoid formation, but is dispensable for their propagation. (A) SI organoids
from Min mice were treated with different concentrations of DBZ. Organoid formation and Apc allelic distribution were assessed at
day 7 to day 8 after seeding. Normal (black arrows) and cyst-like (white arrows) organoids were observed in situ under vehicle and low
dose (1 nM) DBZ treatment (B) but only cyst-like organoids were observed under a high dose (1 μM) DBZ treatment (n = 5 mice, 2
independent experiments). (C) Number of normal versus cyst-like organoids per 1000 crypt nests plated that formed under increasing
concentrations of DBZ. (D–E) Allelic distribution was assessed in single Min organoids +/− DBZ treatment (mice: n = 3). (F) Self-renewal
capacity of vehicle and DBZ treated WT, MybER and Min organoids. (G) NotchIC induces increased cyst-like growth in Min organoids (each
dot represents one mouse and values were derived from at least 5 independent experiments *: p b 0.05; **: p b 0.01).
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Somewhat surprisingly, survival of NotchIC:Min:Myb+/−
mice was not extended compared to NotchIC:Min mice
(Fig. 6A), Min/+ mice spontaneously develop intestinalFigure 6 Myb and Notch status influences colon adenoma formatio
the indicated genotypes is shown. (B) Number of colon adenomas at
each genotype showing indicated symptoms of intestinal adenoma as
**: p b 0.01, ***: p b 0.001, ns: not significant).polyp-like adenomas and far more frequently in the SI
compared to the colon (Moser et al., 1992). In this regard we
found no differences in SI or cecal adenomas between the 4
lines investigated (data not shown) even though, then in Min mice. (A) Kaplan–Meir symptom-free survival of mice of
the time of sickness-related culling. (C) Percentage of mice of
sociated sickness at time of sickness related death. (*: p b 0.05;
362 M. Germann et al.number of colon adenomas was substantially increased from
an average of three perMinmouse to an average of eleven per
NotchIC:Minmouse. Analysis of markers of NotchIC-activating
recombination events (Supplementary Fig. 2A) revealed
that the majority of colon adenomas in NotchIC:Min mice
originated from NotchIC-activated cells (Supplementary
Figs. 2B and C). However, NotchIC:Min adenomas, as well
as Min adenomas, displayed absence of Olfm4 expression
(Supplementary Fig. 2D). The opposite occurs in Min:Myb+/−
mice where there was a significant reduction in colon
adenomas (~1 per mouse) (Fig. 6B) while the number of
SI adenomas remained essentially unchanged (data not
shown) noting that such adenomas must have lost their
ApcWT allele and canonical Wnt signaling is thus consti-
tutively active (Korinek et al., 1997; Luongo et al., 1994).
Nevertheless it would seem that Myb-heterozygosity has a
specific or tissue tropism influencing colon adenoma forma-
tion (Fig. 6B). Interestingly the presence of a single colon
adenoma often precipitates culling a sick mouse even though
the same mouse may have multiple SI adenomas (data not
shown) thus, the decreased tumor load in Myb-heterozygous
mice did not translate into a significant survival benefit
(Figs. 5A and B).
Investigating pathway cross-talk at a
transcriptional level
In view of the apparent genetic interaction between
Notch and Myb we investigated transcript levels of target
genes of either pathway when the other transcription factor
was activated. As described above, mRNA expression of the
Notch target genes Olfm4 and Nrarp was significantly
increased in NotchIC organoids (Figs. 4E and F). This was
independent of Myb+/− (Figs. 4E and F) or MybER and there
was no significant effect onMybmRNA expression itself or its
target gene Ccne1 (Malaterre et al., 2007) (Supplementary
Figs. 4A–C). We then tested whether NotchIC influences the
transcriptional activity on the human Myb promoter using a
reporter assay approach similar to our previous studies
(Cheasley et al., 2011; Ciznadija et al., 2009). To confirm
that the comparable NotchIC vector was active we
transfected HEK293 cells and assessed Notch-endogenous
target gene Hes5 expression which was significantly increased
in a concentration-dependent manner (Supplementary Fig.
4D). By contrast, Hes1 expression was not increased (data not
shown). Under comparable conditions NotchIC did not activate
a reporter construct containing the human Myb promoter
(Supplementary Fig. 4E). Further, NotchIC did not activate the
Myc promoter by itself and did not enhance its activation
through co-operation with Myb and/or β-catenin (Supplemen-
tary Fig. 4F). Therefore, it appears that Myb is not a direct
downstream target of Notch activation and that the apparent
pathway cross-talk was not due to direct activation of
respective transcription factor genes.
Clinical features in adenoma-bearing mice are
influenced by Myb heterozygosity
The ethical determinants for humane management of mice
mean that mice are sacrificed for a spectrum of reasons.
When we assessed the clinical features that underpinnedculling of mice on a Min background we found that mice that
were heterozygous of Myb had reduced levels of, or were
spared from, some pathological symptoms such as bleeding
and the presence of vascularized tumors (Fig. 6C). Similarly,
these same symptoms are exacerbated in MybER-mediated
colon tumors (Malaterre et al., submitted).
Taken together, these results suggest that Notch and Myb
are both crucially involved in initiation of Wnt-pathway-
dependent colon adenomas, while their activation does not
seem to be essential for their further growth and mainte-
nance. This is in agreement with Notch being dispensable for
the intestinal hyperplasia once established following ApcWT
allelic loss (Peignon et al., 2011) and that fully functional Myb
is required for intestinal stem cell activity (Cheasley et al.,
2011) and finally clinical features typically observed in CRC
patients (Malaterre et al., submitted).Discussion
In summary, we have demonstrated that using an in vitro
model of ApcWT-loss and using in vivo intestinal cancer
model that activated Wnt, Notch and Myb are all essential to
intestinal tumorigenesis. We systematically dissected within
the same experimental milieu the influence of the Wnt,
Notch and Myb pathways on optimal formation and growth of
ISC intestinal organoids (or: self-renewal and proliferation of
ISC) in vitro. Using this approach we deconstruct here how
these three pathways interact during the earliest event of
CRC, the initiation of intestinal adenomas, and report a
remarkable shift in their functional and transcriptional
interaction between ISCs and tumor-initiating cells.
Loss of the ApcWT allele in intestinal cells in organoid
culture induces Wnt target genes and high self-renewal
potential in these cells upon which they give rise to
neoplastic growth. This manifests in cyst-like organoids
with aberrant tissue architecture, cell differentiation and
proliferation. In vivo loss of ApcWT in ISC leads to immediate
induction of Wnt signaling and rapid expansion of ISCs
resulting in aberrant tissue architecture and secretory cell
differentiation typical of early intestinal adenomas in mice
(Barker et al., 2009; Sansom et al., 2004). However, these
studies used mice with an induced simultaneous loss of both
Apc alleles, thus circumventing events that influence loss of
Apc function first hand. Therefore, the spontaneous forma-
tion of cyst-like organoids genuinely reflects the initiating
step in intestinal adenoma formation and represents a unique
window to investigate cellular and molecular determinants
of this first step in CRC. Our data suggest that the cyst-like
ApcMin/Min organoids arise from an expansion of cells
positive for the ISC marker Lgr5, but negative for the ISC
marker Olfm4, a detail we find reflected in ApcMin/Min
adenomas. This is in contrast to Olfm4-positive adenomas
formed through Apc loss in Lgr5-positive cells (Myant et al.,
2013; Schepers et al., 2012), suggesting that spontaneous
adenomas in Min mice do arise through a mechanism differing
from induced ApcWT-loss in ISCs.
A benefit of the organoid in vitro system is that it leaves out
interactions of epithelial cells with stromal cells (Akcora et
al., 2013; Barker et al., 2007), which can distort the detection
of epithelial cell-specific signaling pathway interactions in
vivo. Using this approach we wanted to know how the Notch
363Hierarchy of Myb, Wnt and Notch pathways in colon cancerand Myb pathways interact with Wnt signaling during the
transition of ISC to tumor-initiating cells. We confirm findings
of previous studies that loss-of-function of Notch (Pellegrinet
et al., 2011; VanDussen et al., 2012) and Myb (Cheasley et al.,
2011) strongly disturbs ISC self-renewal in vivo and in vitro.
Surprisingly, we find that gain-of-function in these pathways
does not increase self-renewal, suggesting that either both
pathways alone are not sufficient to drive self-renewal, or
their maximal capacity to do so, is limited and cannot be
further increased in organoids.
Importantly we found that Notch activation increases the
number of isolated Min crypts that process to cyst-like
organoids, while Notch activation or inhibition does not
affect growth or self-renewal once the cyst-like growth has
been initiated. This is a striking parallel to the situation in
vivo, where Notch activation increases the number of Wnt
driven adenomas, but does not affect colon adenoma growth
thereafter (Fre et al., 2009; Peignon et al., 2011).
Intriguingly, we did not find any significant differences in
SI adenoma formation across the genotypes on an Apcmin/+
background and we think this is because the activation of the
Wnt pathway in the SI swamps out the effects of the other
pathways. However, Notch activation and MybER had a
significant effect in the colon in terms of adenoma formation
and as colon cancer is approximately 10 times more common
in humans we suggest that this was a more relevant matter
to pursue. One explanation for this phenomenon is that
Notch activation increases the number of tumor-initiating
cells upon ApcWT-loss in the colon. This arguably can happen
on three functional levels where we know aberrant Wnt
activity affects initiation of intestinal adenomas: either by
symmetric division of ISCs (Bellis et al., 2012), by the
induction of a SC program in non-ISCs (Schwitalla et al.,
2013) or by influencing the number of cells with ApcWT-loss
able to clonally expand (Vermeulen et al., 2013). Notch
activation leads to increased expression of the ISC markers
Lgr5 and Olfm4, while the Lgr5-positive/Olfm4-negative
phenotype of ApcMin/Min cyst-like organoids remains the
same when Notch is activated and this is replicated in
adenomas. This indicates that Notch-activation can affect
the ISC phenotype, but does not affect the phenotype of
tumor-initiating cells. Apparently the mechanism of how
Notch influences adenoma initiation is complex and further
studies will be necessary to elucidate it.
In contrast to Notch Myb activation does not affect
cyst-like organoid formation, although MybER increases the
percentage of isolated crypts capable of forming an organoid
and increases adenoma formation in vivo (Malaterre et al.,
manuscript submitted). Interesting in this context is that
MybER induces Myc expression in organoids, a gene which is
essential for Wnt driven adenomas (Sansom et al., 2007).
Myb deficiency on the other hand decreases the number of
adenomas, both if Wnt alone or Wnt and Notch are
hyper-activated, and decreases normal organoid formation
(Cheasley et al., 2011). Although Myb expression in ISCs is
clearly important for their function, it becomes evident that
the role of Myb in intestinal tumor formation cannot be
purely intrinsic to tumor cells and may involve cells within
the tumor environment not present in organoid culture. In
fact we recently found that Myb expression in intestinal
tumor cells affects tumor vasculature (Malaterre et al.,
manuscript submitted), which further might explain thedifferences of symptoms associated with intestinal bleed-
ings that we describe here for Myb-heterozygous tumor
bearing mice.
We previously showed that Myb interacts with Wnt
signaling to regulate Lgr5 expression (Cheasley et al., 2011).
Here we demonstrate for the first time that Notch-activity
also regulates Lgr5 expression and that Myb is involved in this.
Our results nevertheless suggest that Notch does not achieve
this through regulating Myb and Wnt activity, as in organoids
Notch does not appear to influence other classic Myb and Wnt
target genes or vice versa. Therefore, although all three
pathways are known to activate distinct target genes, in
organoids they combine on the regulation of two things: ISC
function and activation of Lgr5 expression. Lgr5 itself is a
co-regulator of Wnt signals (Carmon et al., 2011; Ruffner et
al., 2012) and it is tempting to speculate that Lgr5 at least
partially mediates the promotion of ISCs through Wnt, Notch
and Myb. Furthermore, induction of Lgr5 expression through
Wnt hyperactivation could result in a positive feedback loop,
which might partially explain the independence from Notch
and Myb signals in ApcMin/Min cells.
In conclusion, we demonstrate here that the Wnt, Notch
and Myb pathways are essential for ISC function and
co-regulate Lgr5 expression. Nonetheless, only hyperactiva-
tion of Wnt leads to the transformation of ISCs to
tumor-initiating cells, at the same time rendering them
independent of Notch and Myb signals (see Graphical
abstract). The clinical consequence of this is that Notch
targeting therapies, such as γ-secretase inhibitors, might at
best have a preventive role for CRC, but may fail in later
stages of the disease. Furthermore, our data show that
blocking Notch in vitro selectively kills normal ISC, sparing
adenoma-like cells. Thus these findings raise an important
concern about the possible benefits of some Notch inhibiting
therapies for established CRC. Myb, on the other hand, is
over-expressed in the majority of CRCs (Ramsay and Gonda,
2008) and we have previously shown that the Myb oncoprotein
is a valid therapeutic target both in preventive and adjuvant
settings (Carpinteri et al., 2012; Williams et al., 2008). This
discrepancy might be explained by the possibility that
targeting Myb is not solely confined to tumor cells, but also
on their interaction with the tumor environment. Collectively,
the results presented here highlight that the Wnt pathway
remains as the focal point of intervention to target tumor
initiating and tumor sustaining cells, which should be
considered for CRC therapy.
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http://dx.doi.org/10.1016/j.scr.2014.08.002.Author contribution
MG: concept and design, collection and assembly of data,
data analysis and interpretation and manuscript writing. HX:
collection and assembly of data, data analysis and interpre-
tation. JM: collection and assembly of data, data analysis
and interpretation. SS: collection and assembly of data. MH:
data analysis and interpretation. DC: data analysis and
interpretation. SF: concept and design, provision of study
material, manuscript writing. RGR: conception and design,
provision of study material, collection and assembly of data,
data analysis and interpretation and manuscript writing.
364 M. Germann et al.Acknowledgments
We would like to thank our colleagues at the Peter MacCallum
Animal and Microscopy core facilities for their outstanding assis-
tance and Prof Anthony Burgess for his highly valuable revision of
the manuscript. This work was supported by a NHMRC Program Grant
#487922, NHMRC Project Grant #1007659 and NHMRC Senior
Research Fellowship #APP1002117 and a Rothschild-Yvette Mayent-
Institut Curie Award Sabbatical Fellowship, Curie Institute, Paris
(2009) to R.G.R. MG is supported by a Fellowship from the Swiss
Science Foundation and the Novartis Foundation, Switzerland. SF
was funded by the Association pour la Recherche contre le Cancer
(ARC).
References
Akcora, D., Huynh, D., Lightowler, S., Germann, M., Robine, S., de
May, J.R., Pollard, J.W., Stanley, E.R., Malaterre, J., Ramsay, R.G.,
2013. The CSF-1 receptor fashions the intestinal stem cell niche.
Stem Cell Res. 10 (2), 203–212. http://dx.doi.org/10.1016/j.scr.
2012.12.001.
Andreu, P., Colnot, S., Godard, C., Gad, S., Chafey, P., Niwa-
Kawakita, M., Laurent-Puig, P., Kahn, A., Robine, S., Perret, C.,
Romagnolo, B., 2005. Crypt-restricted proliferation and com-
mitment to the Paneth cell lineage following Apc loss in the
mouse intestine. Development 132 (6), 1443–1451. http://dx.
doi.org/10.1242/dev.01700.
Aoki, K., Taketo, M.M., 2007. Adenomatous polyposis coli (APC): a
multi-functional tumor suppressor gene. J. Cell Sci. 120 (Pt 19),
3327–3335.
Barker, N., van Es, J.H., Kuipers, J., Kujala, P., van den Born, M.,
Cozijnsen, M., Haegebarth, A., Korving, J., Begthel, H., Peters,
P.J., Clevers, H., 2007. Identification of stem cells in small
intestine and colon by marker gene Lgr5. Nature 449 (7165),
1003–1007. http://dx.doi.org/10.1038/nature06196.
Barker, N., Ridgway, R.A., van Es, J.H., van de Wetering, M.,
Begthel, H., van den Born, M., Danenberg, E., Clarke, A.R.,
Sansom, O.J., Clevers, H., 2009. Crypt stem cells as the cells-of-
origin of intestinal cancer. Nature 457 (7229), 608–611.
Barker, N., Bartfeld, S., Clevers, H., 2010. Tissue-resident adult
stem cell populations of rapidly self-renewing organs. Cell
Stem Cell 7 (6), 656–670. http://dx.doi.org/10.1016/j.stem.2010.
11.016.
Batlle, E., Bacani, J., Begthel, H., Jonkheer, S., Gregorieff, A.,
van de Born, M., Malats, N., Sancho, E., Boon, E., Pawson, T.,
Gallinger, S., Pals, S., Clevers, H., 2005. EphB receptor activity
suppresses colorectal cancer progression. Nature 435 (7045),
1126–1130. http://dx.doi.org/10.1038/nature03626 (nature03626
[pii]).
Bellis, J., Duluc, I., Romagnolo, B., Perret, C., Faux, M.C., Dujardin,
D., Formstone, C., Lightowler, S., Ramsay, R.G., Freund, J.N.,
De Mey, J.R., 2012. The tumor suppressor Apc controls planar
cell polarities central to gut homeostasis. J. Cell Biol. 198 (3),
331–341. http://dx.doi.org/10.1083/jcb.201204086.
Carmon, K.S., Gong, X., Lin, Q., Thomas, A., Liu, Q., 2011. R-
spondins function as ligands of the orphan receptors LGR4 and
LGR5 to regulate Wnt/beta-catenin signaling. Proc. Natl. Acad.
Sci. U. S. A. 108 (28), 11452–11457. http://dx.doi.org/10.1073/
pnas.1106083108.
Carpinteri, S., Williams, B.B., Miao, R.Y., C. C., Malaterre, J.,
Norris, M.D., Haber, M., Anderson, R.L., Darcy, P.K., Ramsay, R.G.,
2012. Optimizing DNA vaccines against nuclear oncogenes. Immuno-
Gastroenterology 1 (2), 108–118.
Cheasley, D., Pereira, L., Lightowler, S., Vincan, E., Malaterre, J.,
Ramsay, R.G., 2011. Myb controls intestinal stem cell genes and
self-renewal. Stem Cells 29 (12), 2042–2050. http://dx.doi.org/
10.1002/stem.761.Ciznadija, D., Tothill, R., Waterman, M.L., Zhao, L., Huynh, D., Yu,
R.M., Ernst, M., Ishii, S., Mantamadiotis, T., Gonda, T.J.,
Ramsay, R.G., Malaterre, J., 2009. Intestinal adenoma formation
and MYC activation are regulated by cooperation between MYB
and Wnt signaling. Cell Death Differ. 16 (11), 1530–1538. http://
dx.doi.org/10.1038/cdd.2009.94 (cdd200994 [pii]).
Clevers, H., Nusse, R., 2012. Wnt/beta-catenin signaling and
disease. Cell 149 (6), 1192–1205. http://dx.doi.org/10.1016/j.
cell.2012.05.012.
Efstratiadis, A., Szabolcs, M., Klinakis, A., 2007. Notch, Myc and
breast cancer. Cell Cycle 6 (4), 418–429 (3838 [pii]).
Farin, H.F., Van Es, J.H., Clevers, H., 2012. Redundant sources of
Wnt regulate intestinal stem cells and promote formation of
Paneth cells. Gastroenterology 143 (6), 1518–1529. http://dx.
doi.org/10.1053/j.gastro.2012.08.031 (e1517).
Fre, S., Huyghe, M., Mourikis, P., Robine, S., Louvard, D., Artavanis-
Tsakonas, S., 2005. Notch signals control the fate of immature
progenitor cells in the intestine. Nature 435 (7044), 964–968.
Fre, S., Pallavi, S.K., Huyghe, M., Lae, M., Janssen, K.P., Robine, S.,
Artavanis-Tsakonas, S., Louvard, D., 2009. Notch and Wnt
signals cooperatively control cell proliferation and tumorigen-
esis in the intestine. Proc. Natl. Acad. Sci. U. S. A. 106 (15),
6309–6314.
Fre, S., Hannezo, E., Sale, S., Huyghe, M., Lafkas, D., Kissel, H.,
Louvi, A., Greve, J., Louvard, D., Artavanis-Tsakonas, S., 2011.
Notch lineages and activity in intestinal stem cells determined
by a new set of knock-in mice. PLoS ONE 6 (10), e25785. http://
dx.doi.org/10.1371/journal.pone.0025785.
He, T.C., Sparks, A.B., Rago, C., Hermeking, H., Zawel, L., da
Costa, L.T., Morin, P.J., Vogelstein, B., Kinzler, K.W., 1998.
Identification of c-MYC as a target of the APC pathway. Science
281 (5382), 1509–1512.
Jarde, T., Evans, R.J., McQuillan, K.L., Parry, L., Feng, G.J.,
Alvares, B., Clarke, A.R., Dale, T.C., 2013. In vivo and in vitro
models for the therapeutic targeting of Wnt signaling using a
Tet-ODeltaN89beta-catenin system. Oncogene 32 (7), 883–893.
http://dx.doi.org/10.1038/onc.2012.103.
Jensen, J., Pedersen, E.E., Galante, P., Hald, J., Heller, R.S.,
Ishibashi, M., Kageyama, R., Guillemot, F., Serup, P., Madsen,
O.D., 2000. Control of endodermal endocrine development by
Hes-1. Nat. Genet. 24 (1), 36–44. http://dx.doi.org/10.1038/
71657.
Kim, H.A., Koo, B.K., Cho, J.H., Kim, Y.Y., Seong, J., Chang, H.J.,
Oh, Y.M., Stange, D.E., Park, J.G., Hwang, D., Kong, Y.Y., 2012.
Notch1 counteracts WNT/beta-catenin signaling through chro-
matin modification in colorectal cancer. J. Clin. Invest. 122 (9),
3248–3259. http://dx.doi.org/10.1172/JCI61216.
Kinzler, K.W., Vogelstein, B., 1996. Lessons from hereditary
colorectal cancer. Cell 87 (2), 159–170.
Klinakis, A., Szabolcs, M., Politi, K., Kiaris, H., Artavanis-Tsakonas, S.,
Efstratiadis, A., 2006. Myc is a Notch1 transcriptional target and a
requisite for Notch1-induced mammary tumorigenesis in mice.
Proc. Natl. Acad. Sci. U. S. A. 103 (24), 9262–9267. http://dx.doi.
org/10.1073/pnas.0603371103 (0603371103 [pii]).
Kopan, R., Ilagan, M.X., 2009. The canonical Notch signaling
pathway: unfolding the activation mechanism. Cell 137 (2),
216–233. http://dx.doi.org/10.1016/j.cell.2009.03.045.
Korinek, V., Barker, N., Morin, P.J., van Wichen, D., de Weger, R.,
Kinzler, K.W., Vogelstein, B., Clevers, H., 1997. Constitutive
transcriptional activation by a beta-catenin-Tcf complex in
APC−/− colon carcinoma. Science 275 (5307), 1784–1787.
Korinek, V., Barker, N., Moerer, P., van Donselaar, E., Huls, G.,
Peters, P.J., Clevers, H., 1998. Depletion of epithelial stem-cell
compartments in the small intestine of mice lacking Tcf-4. Nat.
Genet. 19 (4), 379–383. http://dx.doi.org/10.1038/1270.
Luongo, C., Moser, A.R., Gledhill, S., Dove, W.F., 1994. Loss of Apc+
in intestinal adenomas from Min mice. Cancer Res. 54 (22),
5947–5952.
365Hierarchy of Myb, Wnt and Notch pathways in colon cancerMalaterre, J., Carpinelli, M., Ernst, M., Alexander, W., Cooke, M.,
Sutton, S., Dworkin, S., Heath, J.K., Frampton, J., McArthur, G.,
Clevers, H., Hilton, D., Mantamadiotis, T., Ramsay, R.G., 2007.
c-Myb is required for progenitor cell homeostasis in colonic
crypts. Proc. Natl. Acad. Sci. U. S. A. 104 (10), 3829–3834.
http://dx.doi.org/10.1073/pnas.0610055104 (0610055104 [pii]).
Moser, A.R., Pitot, H.C., Dove, W.F., 1990. A dominant mutation
that predisposes to multiple intestinal neoplasia in the mouse.
Science 247 (4940), 322–324.
Moser, A.R., Dove, W.F., Roth, K.A., Gordon, J.I., 1992. The Min
(multiple intestinal neoplasia) mutation: its effect on gut
epithelial cell differentiation and interaction with a modifier
system. J. Cell Biol. 116 (6), 1517–1526.
Muncan, V., Sansom, O.J., Tertoolen, L., Phesse, T.J., Begthel, H.,
Sancho, E., Cole, A.M., Gregorieff, A., de Alboran, I.M., Clevers,
H., Clarke, A.R., 2006. Rapid loss of intestinal crypts upon
conditional deletion of the Wnt/Tcf-4 target gene c-Myc. Mol.
Cell. Biol. 26 (22), 8418–8426. http://dx.doi.org/10.1128/MCB.
00821-06 (MCB.00821-06 [pii]).
Murtaugh, L.C., Stanger, B.Z., Kwan, K.M., Melton, D.A., 2003.
Notch signaling controls multiple steps of pancreatic differenti-
ation. Proc. Natl. Acad. Sci. U. S. A. 100 (25), 14920–14925.
http://dx.doi.org/10.1073/pnas.2436557100 2436557100 (pii).
Myant, K.B., Cammareri, P., McGhee, E.J., Ridgway, R.A., Huels, D.J.,
Cordero, J.B., Schwitalla, S., Kalna, G., Ogg, E.L., Athineos, D.,
Timpson, P., Vidal, M., Murray, G.I., Greten, F.R., Anderson, K.I.,
Sansom, O.J., 2013. ROS production and NF-kappaB activation
triggered by RAC1 facilitate WNT-driven intestinal stem cell
proliferation and colorectal cancer initiation. Cell Stem Cell 12
(6), 761–773. http://dx.doi.org/10.1016/j.stem.2013.04.006.
Onuma, K., Ochiai, M., Orihashi, K., Takahashi, M., Imai, T.,
Nakagama, H., Hippo, Y., 2013. Genetic reconstitution of
tumorigenesis in primary intestinal cells. Proc. Natl. Acad. Sci.
U. S. A. 110 (27), 11127–11132. http://dx.doi.org/10.1073/pnas.
1221926110.
Peignon, G., Durand, A., Cacheux, W., Ayrault, O., Terris, B.,
Laurent-Puig, P., Shroyer, N.F., Van Seuningen, I., Honjo, T.,
Perret, C., Romagnolo, B., 2011. Complex interplay between
beta-catenin signalling and Notch effectors in intestinal tumor-
igenesis. Gut 60 (2), 166–176. http://dx.doi.org/10.1136/gut.
2009.204719.
Pellegrinet, L., Rodilla, V., Liu, Z., Chen, S., Koch, U., Espinosa, L.,
Kaestner, K.H., Kopan, R., Lewis, J., Radtke, F., 2011. Dll1- and
dll4-mediated notch signaling are required for homeostasis of
intestinal stem cells. Gastroenterology 140 (4), 1230–1240.
http://dx.doi.org/10.1053/j.gastro.2011.01.005 (e1237. S0016-
5085(11)00039-4 [pii]).
Powell, S.M., Zilz, N., Beazer-Barclay, Y., Bryan, T.M., Hamilton, S.R.,
Thibodeau, S.N., Vogelstein, B., Kinzler, K.W., 1992. APC
mutations occur early during colorectal tumorigenesis. Nature
359 (6392), 235–237.
Ramsay, R.G., Gonda, T.J., 2008. MYB function in normal and
cancer cells. Nat. Rev. Cancer 8 (7), 523–534. http://dx.doi.
org/10.1038/nrc2439 (nrc2439 [pii]).
Ramsay, R.G., Ciznadija, D., Sicurella, C., Reyes, N., Mitchelhill, K.,
Darcy, P.K., D'Abaco, G., Mantamadiotis, T., 2005. Colon
epithelial cell differentiation is inhibited by constitutive c-myb
expression or mutant APC plus activated RAS. DNA Cell Biol. 24
(1), 21–29.
Ruffner, H., Sprunger, J., Charlat, O., Leighton-Davies, J.,
Grosshans, B., Salathe, A., Zietzling, S., Beck, V., Therier, M.,
Isken, A., Xie, Y., Zhang, Y., Hao, H., Shi, X., Liu, D., Song, Q.,
Clay, I., Hintzen, G., Tchorz, J., Bouchez, L.C., Michaud, G.,
Finan, P., Myer, V.E., Bouwmeester, T., Porter, J., Hild, M.,
Bassilana, F., Parker, C.N., Cong, F., 2012. R-spondin potenti-
ates Wnt/beta-catenin signaling through orphan receptors LGR4
and LGR5. PLoS ONE 7 (7), e40976. http://dx.doi.org/10.1371/
journal.pone.0040976.Sansom, O.J., Reed, K.R., Hayes, A.J., Ireland, H., Brinkmann, H.,
Newton, I.P., Batlle, E., Simon-Assmann, P., Clevers, H.,
Nathke, I.S., Clarke, A.R., Winton, D.J., 2004. Loss of Apc in
vivo immediately perturbs Wnt signaling, differentiation, and
migration. Genes Dev. 18 (12), 1385–1390.
Sansom, O.J., Meniel, V.S., Muncan, V., Phesse, T.J., Wilkins, J.A.,
Reed, K.R., Vass, J.K., Athineos, D., Clevers, H., Clarke, A.R.,
2007. Myc deletion rescues Apc deficiency in the small intestine.
Nature 446 (7136), 676–679.
Sato, T., Vries, R.G., Snippert, H.J., van de Wetering, M., Barker, N.,
Stange, D.E., van Es, J.H., Abo, A., Kujala, P., Peters, P.J.,
Clevers, H., 2009. Single Lgr5 stem cells build crypt-villus
structures in vitro without a mesenchymal niche. Nature 459
(7244), 262–265. http://dx.doi.org/10.1038/nature07935.
Sato, T., Stange, D.E., Ferrante, M., Vries, R.G., Van Es, J.H., Van
den Brink, S., Van Houdt, W.J., Pronk, A., Van Gorp, J.,
Siersema, P.D., Clevers, H., 2011a. Long-term expansion of
epithelial organoids from human colon, adenoma, adenocarci-
noma, and Barrett's epithelium. Gastroenterology 141 (5),
1762–1772. http://dx.doi.org/10.1053/j.gastro.2011.07.050.
Sato, T., van Es, J.H., Snippert, H.J., Stange, D.E., Vries, R.G., van
den Born, M., Barker, N., Shroyer, N.F., van de Wetering, M.,
Clevers, H., 2011b. Paneth cells constitute the niche for Lgr5
stem cells in intestinal crypts. Nature 469 (7330), 415–418.
http://dx.doi.org/10.1038/nature09637.
Schepers, A.G., Snippert, H.J., Stange, D.E., van den Born, M., van
Es, J.H., van de Wetering, M., Clevers, H., 2012. Lineage tracing
reveals Lgr5+ stem cell activity in mouse intestinal adenomas.
Science 337 (6095), 730–735. http://dx.doi.org/10.1126/
science.1224676.
Schwitalla, S., Fingerle, A.A., Cammareri, P., Nebelsiek, T.,
Goktuna, S.I., Ziegler, P.K., Canli, O., Heijmans, J., Huels, D.J.,
Moreaux, G., Rupec, R.A., Gerhard, M., Schmid, R., Barker, N.,
Clevers, H., Lang, R., Neumann, J., Kirchner, T., Taketo, M.M.,
van den Brink, G.R., Sansom, O.J., Arkan, M.C., Greten, F.R.,
2013. Intestinal tumorigenesis initiated by dedifferentiation and
acquisition of stem-cell-like properties. Cell 152 (1–2), 25–38.
http://dx.doi.org/10.1016/j.cell.2012.12.012.
Smith, E., Claudinot, S., Lehal, R., Pellegrinet, L., Barrandon, Y.,
Radtke, F., 2012. Generation and characterization of a Notch1
signaling-specific reporter mouse line. Genesis 50 (9), 700–710.
http://dx.doi.org/10.1002/dvg.22030.
Sparks, A.B., Morin, P.J., Vogelstein, B., Kinzler, K.W., 1998.
Mutational analysis of the APC/beta-catenin/Tcf pathway in
colorectal cancer. Cancer Res. 58 (6), 1130–1134.
Taketo, M.M., 2006. Mouse models of gastrointestinal tumors.
Cancer Sci. 97 (5), 355–361.
van der Flier, L.G., van Gijn, M.E., Hatzis, P., Kujala, P.,
Haegebarth, A., Stange, D.E., Begthel, H., van den Born, M.,
Guryev, V., Oving, I., van Es, J.H., Barker, N., Peters, P.J., van
de Wetering, M., Clevers, H., 2009. Transcription factor achaete
scute-like 2 controls intestinal stem cell fate. Cell 136 (5),
903–912. http://dx.doi.org/10.1016/j.cell.2009.01.031.
van Es, J.H., Jay, P., Gregorieff, A., van Gijn, M.E., Jonkheer, S.,
Hatzis, P., Thiele, A., van den Born, M., Begthel, H., Brabletz, T.,
Taketo, M.M., Clevers, H., 2005a. Wnt signalling induces matura-
tion of Paneth cells in intestinal crypts. Nat. Cell Biol. 7 (4),
381–386. http://dx.doi.org/10.1038/ncb1240 (ncb1240 [pii]).
van Es, J.H., van Gijn, M.E., Riccio, O., van den Born, M., Vooijs, M.,
Begthel, H., Cozijnsen, M., Robine, S., Winton, D.J., Radtke, F.,
Clevers, H., 2005b. Notch/gamma-secretase inhibition turns
proliferative cells in intestinal crypts and adenomas into goblet
cells. Nature 435 (7044), 959–963.
van Es, J.H., Haegebarth, A., Kujala, P., Itzkovitz, S., Koo, B.K.,
Boj, S.F., Korving, J., van den Born, M., van Oudenaarden, A.,
Robine, S., Clevers, H., 2012. A critical role for the Wnt effector
Tcf4 in adult intestinal homeostatic self-renewal. Mol. Cell. Biol.
32 (10), 1918–1927. http://dx.doi.org/10.1128/MCB.06288-11.
366 M. Germann et al.VanDussen, K.L., Carulli, A.J., Keeley, T.M., Patel, S.R., Puthoff, B.J.,
Magness, S.T., Tran, I.T., Maillard, I., Siebel, C., Kolterud, A.,
Grosse, A.S., Gumucio, D.L., Ernst, S.A., Tsai, Y.H., Dempsey, P.J.,
Samuelson, L.C., 2012. Notch signaling modulates proliferation and
differentiation of intestinal crypt base columnar stem cells.
Development 139 (3), 488–497. http://dx.doi.org/10.1242/dev.
070763.
Vermeulen, L., De Sousa, E.M.F., van der Heijden, M., Cameron, K.,
de Jong, J.H., Borovski, T., Tuynman, J.B., Todaro, M., Merz, C.,
Rodermond, H., Sprick, M.R., Kemper, K., Richel, D.J., Stassi, G.,
Medema, J.P., 2013. Wnt activity defines colon cancer stem cells
and is regulated by the microenvironment. Nat. Cell Biol. 12 (5),
468–476.Williams, B.B., Wall, M., Miao, R.Y., Williams, B., Bertoncello, I.,
Kershaw, M.H., Mantamadiotis, T., Haber, M., Norris, M.D.,
Gautam, A., Darcy, P.K., Ramsay, R.G., 2008. Induction of T cell-
mediated immunity using a c-Myb DNA vaccine in a mouse model
of colon cancer. Cancer Immunol. Immunother. 57 (11),
1635–1645. http://dx.doi.org/10.1007/s00262-008-0497-2.
Yang, Q., Bermingham, N.A., Finegold, M.J., Zoghbi, H.Y., 2001.
Requirement of Math1 for secretory cell lineage commitment in
the mouse intestine. Science 294 (5549), 2155–2158.
